Common Contracts

HEALTH INSURANCE INNOVATIONS, INC. 3,000,000 Shares CLASS A Common Stock ($0.001 par value) Underwriting Agreement

Underwriting Agreement • March 8th, 2017 • Health Insurance Innovations, Inc. • Insurance agents, brokers & service • New York

• Contract Type
  Underwriting Agreement
• Filed
  March 8th, 2017
• Company
  Health Insurance Innovations, Inc.
• Industry
  Insurance agents, brokers & service
• Jurisdiction
  New York

ACTINIUM PHARMACEUTICALS, INC. 8,000,000 Shares Common Stock ($0.001 par value) Underwriting Agreement Underwriting Agreement

Underwriting Agreement • September 29th, 2016 • Actinium Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Underwriting Agreement
• Filed
  September 29th, 2016
• Company
  Actinium Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

ACTINIUM PHARMACEUTICALS, INC. 1,670,000 Shares Common Stock ($0.001 par value) Underwriting Agreement

Underwriting Agreement • June 25th, 2014 • Actinium Pharmaceuticals, Inc. • Blank checks • New York

• Contract Type
  Underwriting Agreement
• Filed
  June 25th, 2014
• Company
  Actinium Pharmaceuticals, Inc.
• Industry
  Blank checks
• Jurisdiction
  New York

LEMAITRE VASCULAR, INC. 1,430,000 Shares Common Stock ($0.01 par value) Underwriting Agreement

Underwriting Agreement • May 30th, 2014 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • New York

• Contract Type
  Underwriting Agreement
• Filed
  May 30th, 2014
• Company
  Lemaitre Vascular Inc
• Industry
  Surgical & medical instruments & apparatus
• Jurisdiction
  New York

LeMaitre Vascular, Inc., a Delaware corporation (the “Company”), confirms its agreement pursuant to this Underwriting Agreement (this “Agreement”) to the several underwriters listed on Schedule A attached hereto (collectively, the “Underwriters”), for whom Canaccord Genuity Inc. and Stifel, Nicolaus & Company, Incorporated are acting as representatives (in such capacity, the “Representatives”), with respect to the issue and sale by the Company of an aggregate total of 1,430,000 shares (the “Firm Shares”) of the Company’s common stock, $0.01 par value (the “Common Stock”), the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of Firm Shares set forth in Schedule A hereto, and with respect to the grant by the Company to the Underwriters, acting severally and not jointly, of the option described in Section 1 hereof to purchase all or any part of 214,500 additional shares of Common Stock to cover over-allotments, if any. The Firm Shares and all or an